Takeda Test Drives EMA’s Parallel Review Route For EU And Non-EU Markets

Company Submits Two Sets Of Applications For Evaluation Of Its Dengue Vaccine To CHMP

 
• By Vibha Sharma

A new evaluation route that the European Medicines Agency launched last year came at the right time for Takeda’s dengue vaccine candidate. 

Dengue - Phrase in History of the Present Illness
Dengue is the most rapidly spreading mosquito-borne disease • Source: Alamy

More from Review Pathways

More from Pathways & Standards